REDWOOD CITY, Calif., Nov 01, 2022 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, today announced it will host a conference call on Monday, November 14, 2022 at 4:30 p.m. ET to discuss its financial results for the fiscal 2023 second quarter and provide a business update.
Financial Results Conference Call
Additional details are available under the Investor Relations section of the Company’s website: https://www.biotricity.com/investors/
| Event: | Biotricity Fiscal 2023 Second Quarter Financial Results Conference Call |
| Date: | Monday, November 14, 2022 |
| Time: | 4:30 p.m. Eastern Time |
| Live Call: | 1-866-575-6539 (U.S. Toll-Free) or 1-646-828-8193 (International) |
| Webcast: | https://viavid.webcasts.com/starthere.jsp?ei=1579691&tp_key=ec8c6fdf26 |
For interested individuals unable to join the conference call, a dial-in replay of the call will be available until November 28, 2022 and can be accessed by dialing +1-844-512-2921 (U.S. Toll Free) or +1-412-317-6671 (International) and entering replay pin number: 8592059.
About Biotricity Inc.
Biotricity is reforming the healthcare market by bridging the gap in remote monitoring and chronic care management. Doctors and patients trust Biotricity’s unparalleled standard for preventive & personal care, including diagnostic and post-diagnostic solutions for chronic conditions. The company develops comprehensive remote health monitoring solutions for the medical and consumer markets. To learn more, visit www.biotricity.com.
Contacts:
Investor relations:
KCSA Strategic Communications
Valter Pinto or Jack Perkins
(212) 896-1254
Investors@biotricity.com
